Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes-Reference-Cited by-同舟云学术

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes

Published:2014-08 Issue:1-2 Volume:394 Page:13-20
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Bernardi Stella^ORCID,Fabris Bruno,Thomas Merlin,Toffoli Barbara,Tikellis Christos,Candido Riccardo,Catena Cristiana,Mulatero Paolo,Barbone Fabio,Radillo Oriano,Zauli Giorgio,Secchiero Paola

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference55 articles.

1. Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome;Akinci;Diabetes Res. Clin. Pract.,2011

2. Metabolic syndrome – a new world-wide definition. A Consensus statement from the international diabetes federation;Alberti;Diabet. Med.,2006

3. Expression and regulation of osteoprotegerin in adipose tissue;An;Yonsei Med. J.,2007

5. Osteoprotegerin as a marker of atherosclerosis in diabetic patients;Augoulea;Int. J. Endocrinol.,2013

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of bone in energy metabolism: A focus on osteocalcin;Bone;2024-11

2. Osteokines in Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2024-09-03

3. Osteoprotegerin mediates adipogenesis in obesity;Journal of Advanced Research;2024-08

4. Osteoprotegerin Is Essential for the Development of Endothelial Dysfunction Induced by Angiotensin II in Mice;International Journal of Molecular Sciences;2024-06-11

5. Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2023-05-19